Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of Hexosediphosphatase by Sulphhydryl Reagents and by Ascorbic Acid

Abstract

DURING the course of an investigation of the action of vitamin K and its biological antagonists (dicoumarol, salicylate) on various phosphatases, details of which will be published elsewhere, it was observed that liver hexosediphosphatase1 exhibited a much greater sensitivity towards quinones than did the other phosphatases. Purified bone phosphomonoesterase2, for example, required a concentration of 10-3 M benzoquinone for complete inactivation, whereas 10-5 M benzoquinone was sufficient completely to inhibit the hexosediphosphatase.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WALSH, E., WALSH, G. Inhibition of Hexosediphosphatase by Sulphhydryl Reagents and by Ascorbic Acid. Nature 161, 976–977 (1948). https://doi.org/10.1038/161976b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/161976b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing